TL;DRLast August, the FDA contacted WHOOP about concerns with its blood pressure analysis.Ever since then, the two have been working to negotiate an mutually agreeable solution.This week, the FDA has signed off on WHOOP’s new approach, incorporating some labeling changes.For as much as we might love fitness wearables that are just utterly packed with sensors, manufacturers of these devices need to be very careful about whether all that data they’re gathering ends up classifying them as a “medical device” in the eyes of the FDA — and correspondingly, opening them up to that much more scrutiny. Last summer, we learned that the FDA was not happy about how WHOOP’s MG (Medical Grade) wearable was attempting to offer blood pressure analysis. Now, 10 months later, the government has finally worked things out with WHOOP.According to Bloomberg, the FDA formally gave WHOOP the go-ahead for continuing to offer its blood pressure tool earlier this week. While the agency first warned the company about its concerns last August, WHOOP immediately pushed back, and never actually ended up disabling blood pressure support.